Back

The relationship between serotonin transporter occupancy and extracellular serotonin concentration is hyperbolic, not linear: implications for safely tapering antidepressants

Cohrs, D.; Shapiro, B.

2026-06-18 psychiatry and clinical psychology
10.64898/2026.06.09.26355019 medRxiv
Show abstract

Background: Hyperbolic tapering is an increasingly recognized approach for discontinuing serotonin reuptake inhibitor (SRI) antidepressants that involves non-linear dose reductions with equal stepwise reductions in serotonin transporter (SERT) occupancy to mitigate withdrawal symptoms. Its theoretical basis is the hyperbolic relationship between SRI dose and SERT occupancy reported in radioligand imaging studies. Hyperbolic tapering implicitly assumes that changes in SERT occupancy approximate changes in biologic effect and withdrawal risk. Because SERT occupancy plateaus across the therapeutic dose range of SRIs, this framework predicts relatively small biologic effects and withdrawal risk within this range. However, SERT occupancy influences serotonergic activity only indirectly via its effects on extracellular serotonin concentrations, and the relationship between these two variables is poorly characterized. Methods: We developed a two-pathway clearance model derived from mass-action kinetics to evaluate the steady-state relationship between SERT occupancy and extracellular serotonin concentrations under chronic SRI treatment. Results: Our analysis indicates that serotonin concentrations increase hyperbolically as transporter occupancy increases, suggesting that biologically meaningful differences in serotonergic signaling persist across the therapeutic dose range of SRIs despite plateauing occupancy. Conclusions: Our model predicts a hyperbolic relationship between SERT occupancy and extracellular serotonin concentrations, suggesting that changes in occupancy may not map proportionally onto serotonergic effect. These findings provide a potential mechanistic explanation for dose-dependent clinical effects of SRIs despite plateauing transporter occupancy and generate testable hypotheses regarding antidepressant tapering strategies. Empirical validation is warranted.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 17%
10.9%
2
Psychopharmacology
69 papers in training set
Top 0.1%
8.8%
3
Journal of Psychopharmacology
17 papers in training set
Top 0.1%
5.5%
4
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
71 papers in training set
Top 0.3%
5.5%
5
Neuropsychopharmacology
153 papers in training set
Top 0.6%
5.4%
6
Translational Psychiatry
260 papers in training set
Top 1%
4.8%
7
Biological Psychiatry
137 papers in training set
Top 0.7%
4.4%
8
eLife
5828 papers in training set
Top 30%
4.0%
9
Psychological Medicine
88 papers in training set
Top 0.6%
4.0%
50% of probability mass above
10
Molecular Psychiatry
282 papers in training set
Top 2%
3.2%
11
Frontiers in Pharmacology
111 papers in training set
Top 0.8%
3.2%
12
European Neuropsychopharmacology
20 papers in training set
Top 0.1%
2.8%
13
PLOS Computational Biology
1863 papers in training set
Top 11%
2.6%
14
Scientific Reports
3612 papers in training set
Top 43%
2.4%
15
Journal of Affective Disorders
92 papers in training set
Top 1.0%
2.1%
16
Computational Psychiatry
12 papers in training set
Top 0.1%
1.7%
17
BMC Medicine
176 papers in training set
Top 3%
1.3%
18
Psychiatry Research
41 papers in training set
Top 0.8%
1.3%
19
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 35%
1.1%
20
Journal of Psychiatric Research
32 papers in training set
Top 0.8%
1.1%
21
Communications Medicine
113 papers in training set
Top 4%
1.0%
22
npj Digital Medicine
118 papers in training set
Top 3%
1.0%
23
The Journal of Neuroscience
1025 papers in training set
Top 9%
0.9%
24
Journal of Neurology, Neurosurgery & Psychiatry
30 papers in training set
Top 0.8%
0.8%
25
Wellcome Open Research
67 papers in training set
Top 2%
0.8%
26
Journal of The Royal Society Interface
235 papers in training set
Top 4%
0.8%
27
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 0.4%
0.8%
28
PLOS Medicine
110 papers in training set
Top 3%
0.8%
29
Nature Communications
5641 papers in training set
Top 60%
0.6%
30
F1000Research
88 papers in training set
Top 5%
0.6%